The role of SOX9 in chemoresistance has been reported for multiple tumors as for breast cancer, glioblastoma, cervical cancer, gastric cancer and lung cancer [36,37,38,39,40,41,42]. This evidence concerns the gene SOX9 and gastric cancer.